ClearPoint Neuro
CLPT
28 hedge funds and large institutions have $4.65M invested in ClearPoint Neuro in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
33% more funds holding
Funds holding: 21 → 28 (+7)
11% more capital invested
Capital invested by funds: $4.2M → $4.65M (+$442K)
2.49% more ownership
Funds ownership: 5.76% → 8.25% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$671K |
| 2 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
+$614K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$605K |
| 4 |
Renaissance Technologies
New York
|
+$139K |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$123K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$233K |
| 2 |
Millennium Management
New York
|
-$89K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$50K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$28.6K |
| 5 |
MWM
Merriman Wealth Management
Seattle,
Washington
|
-$22.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
26
Bridgeway Capital Management
Houston,
Texas
| – | -$50K | -10,500 | Closed |
|
27
UBS Group
Zurich,
Switzerland
| – | -$14.4K | -2,938 | -100% |
|
28
Wells Fargo
San Francisco,
California
| – | +$324 | +66 | New |
|
CLPT Hedge Fund Activity: Q1 2020 in Review
28 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q1 2020, worth a combined $4.65M — up 11% from $4.2M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CLPT positions and 1 closed out — a net gain of 8 holders — while 3 added to existing stakes and 8 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $671K. The largest seller was Bank of America, cutting an estimated $233K.
- 28 institutional investors held ClearPoint Neuro (CLPT) as of Q1 2020, up from 21 in Q4 2019.
- Funds reported $4.65M of ClearPoint Neuro stock for Q1 2020, up 11% quarter-over-quarter.
- 9 funds opened new ClearPoint Neuro positions in Q1 2020 and 1 closed out, a net change of +8 holders.
- The largest ClearPoint Neuro buyer in Q1 2020 was EAM Investors, an estimated $671K added.
- The largest ClearPoint Neuro seller in Q1 2020 was Bank of America, an estimated $233K sold.
Based on aggregated 13F filings for Q1 2020.